Gain Therapeutics Inc. is a biotechnology firm headquartered in Bethesda, Maryland, dedicated to developing innovative therapies aimed at combating diseases related to protein misfolding. Utilizing its proprietary drug discovery platform, the company is advancing a robust pipeline of candidate therapies targeting neurodegenerative and other serious disorders. With a strong emphasis on addressing significant unmet medical needs, Gain Therapeutics is strategically positioned to make impactful contributions to the biopharmaceutical sector, attracting institutional investors interested in pioneering healthcare solutions with transformative potential.
Click "Analyze" to generate stock analysis
GANX Price Trend and Signals
GANX Option Volumes & Open Interests (aggregated)
GANX Put Call Ratios and IV (aggregated)
GANX Financials
2025-10-16Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.
2025-09-30Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-09-30Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-09-30Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.